Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss.
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells.
Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Bone loss with multiple sclerosis: effect of glucocorticoid use and functional status.
Leber hereditary optic neuropathy and multiple sclerosis: the mitochondrial connection.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Not Lost in Translation: Emerging Clinical Importance of the G Protein-Coupled Estrogen Receptor GPER.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
Employment among Patients with Multiple Sclerosis-A Population Study.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
Pages
« first
‹ previous
…
420
421
422
423
424
425
426
427
428
…
next ›
last »